If symptoms > 3 months or prosthetic valve endocarditis, recommend 6 weeks of therapy.

There is preliminary evidence that shorter course (2-3 weeks) gentamicin therapy may be adequate. As such, there should be a low threshold for discontinuing gentamicin in patients with deteriorating renal function (< 30mL/min).